GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MiCo BioMed Co Ltd (XKRX:214610) » Definitions » Research & Development

MiCo BioMed Co (XKRX:214610) Research & Development : ₩3,184 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is MiCo BioMed Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. MiCo BioMed Co's Research & Development for the three months ended in Dec. 2024 was ₩68 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩3,184 Mil.


MiCo BioMed Co Research & Development Historical Data

The historical data trend for MiCo BioMed Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MiCo BioMed Co Research & Development Chart

MiCo BioMed Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,150.45 7,830.74 7,454.46 4,036.26 3,184.40

MiCo BioMed Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,086.67 1,259.18 999.33 858.30 67.58

MiCo BioMed Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,184 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MiCo BioMed Co  (XKRX:214610) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


MiCo BioMed Co Research & Development Related Terms

Thank you for viewing the detailed overview of MiCo BioMed Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


MiCo BioMed Co Business Description

Traded in Other Exchanges
N/A
Address
815, Daewangpangyo-ro, Sujeong-gu, Gyeonggi-do, Seongnam-si, KOR
MiCo BioMed Co Ltd is engaged in developing Bio-Diagnostic Labchip technology, efficient bio-reagents, and portable mini High-Speed diagnostic equipment. It also manufactures medical device and precision instrument.

MiCo BioMed Co Headlines

No Headlines